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ABSTRACT 
Two cases of possible lipoid pneumonia- associated with use of Pam 
cooking oil aerosol stimulated interest in an animal model for prelimi¬ 
nary studies of the potential toxicity of this lipid spray. 
Guinea pigs were exposed to commercial Pam in short and long, up 
to six months, term exposure studies following intubation and intra¬ 
tracheal injection of the oil or inhalation of a brief(15 seconds) spray. 
The long term sprayed animals demonstrated markedly poor growth vs. 
controls with non-significantly different food and water ingestion and 
without evidence of malabsorption. 
Small amounts of oil were observed within alveoli and bronchioles 
of sprayed and intratracheally injected animals. Oil was also noted 
finely dispersed within monocytic cells. Focal mononuclear cell infil¬ 
trate, foamy histiocytes, and, in three animals, giant cells were present; 
these changes increased with greater exposure to the oil and were most 
evident in the intratracheally injected animals receiving several doses. 
Marked eosinophilia of pulmonary lavage cells was noted in the 
animals sprayed for six months vs. controls, with no observed eosinophils. 
The tissue response to Pam was not thought to represent a hypersensitivity 
phenomenon, but rather a foreign body reaction and gradual pulmonary 
clearance of a relatively non-irritating oil. 
These preliminary findings indicate t re need f°r more detailed 
studies to determine the importance of lip:.d aerosols in human respira¬ 
tory disease. 
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INTRODUCTION 
It has become increasingly apparent in recent years that the use 
of aerosol sprays, ubiquitous in the modern American home, is not without 
hazards even when label instructions are followed correctly. Pulmonary 
side-effects differ for atopic individuals, smokers, and those with 
chronic lung disease, particularly the elderly. In the last few years 
the use of aerosolized vegetable oils, ("Pam," "Golden Touch," "Cooking 
Ease," and Mazola No Stick"; see Table I), in domestic cooking has 
become popular. The amount of oil used in pan-frying is less than with 
usual methods and results in fewer calories for foods ordinarily fried. 
Also, these componds do not contain cholesterol. 
F.D.A. (Food and Drug Administration), does not require inhalation 
toxicity studies of aerosol foods or cosmetics by companies, nor does 
it at present envision studying this issue. Aside from fluorocarbon 
propellent inhalation studies, few papers have been published in this 
area. Two patients from Salt Lake City, Utah with presumed lipoid 
pneumonia associated with heavy Pam use stimulated interest in studying 
pulmonary complications secondary to aerosol lipid exposure. Guinea 
pigs were employed as an animal model in short and long term inhalation 
experiments. 
I. Two cases of Possible Lipoid Pneumonia 
Case I. An active 82 year old white male was seen by his private physi¬ 
cian for complaints of shortness of breath, mild cough productive of 
yellow sputum. 15 pound weight loss, and a feeling of "hotness on eating," 
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all of recent onset. His dysnea in fact was so marked that he was unable 
to cross a room without significant symptoms. He denied hemoptysis, 
chest pain, night sweats, pedal edema or other problems. Past medical 
history included spontaneous pneumothorax age 66, abdominal aortic 
aneurysm with successful graft replacement age 68, and probable pulmonary 
emphysema noted on radiologic examination five years previously. The 
patient had smoked one pack per day most of his life. Vital signs were 
within normal limits and physical examination was unremarkable except 
for amphoric breathing in the left axilla. Chest radiograph at this 
time showed new findings of a 10 cm diameter poorly defined consolidation 
in the central portion of the left lung consistent with pneumonia and 
accentuated markings in the central portion of the right lung, thought 
to represent an interstitial pneumonic process. CBC, urinalysis, 
SMA-12 except for a total bilirubin of 1.4, (normal to 1.0), were normal. 
Intermediate strength tuberculin test was nonreactive, two sputums for 
acid-fast bacilli were negative, and sputum cultures grew normal flora. 
Microscopic examination of the sputum revealed polymorphonuclear 
leukocytes and macrophages filled' with oil. 
Bronchoscopy and lung biopsy were suggested but the patient declined 
these procedures. He remained afebrile and was given a trial of Tetra¬ 
cycline, 250 mgm qid x 6 days. Although :he patient reported no clinical 
change, the chest radiographic abnormalities progressed with increased 
diameter of the left mid-lung lesion and greater prominence of the 
markings in the right lung field. 
Two weeks later a four month history >f daily Pam aerosolized 
cooking oil use was obtained. With poor vision due to cataracts, he 
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usually placed his face very near the skillet when spraying. He denied 
nose drops or other oil use. The patient was advised to avoid all aero¬ 
sols and he returned in two weeks feeling better. The patient stated 
that he was able to take much deeper breaths. Repeat chest radiographs 
showed considerable resolution in both lungs. He was begun on Predni¬ 
sone, AO mgm daily x two days, then 20 mgm daily thereafter. 
He was seen two weeks later, feeling much improved. Chest radio¬ 
graph showed some residual markings thought to be interstitial in nature 
and the Prednisone was reduced to 20 mgm every other day. 
Later in the same year the patient experienced a transient ischemic 
episode with subsequent stroke and died a few months later from cardio¬ 
respiratory failure. There was no postmortem examination. 
Case II, A 65 year old white male with COPD presented at the Veterans 
Administration Hospital, Salt Lake City, Utah with shortness of breath, 
dyspnea on walking short distances, and marked cough productive of scanty 
sputum, all progressive over the past few months. He denied other 
problems. Vital signs were within normal limits and physical exam 
was remarkable only for increased A-P diameter. Chest radiograph was 
read as consistent with pneumonia with a diffuse interstitial pattern. 
The patient's sputum was loaded with oil, free and within macrophages. 
No history of oil ingestion or nasal instillation was obtained; however, 
the patient i sed Pam "many" times a day, and sprayed into a pan already 
heating on the stove. The patient was advised to stop using the Pam 
spray and his symptoms disappeared along with gradual improvement of 
his chest radiograph. 
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These two cases do not prove pulmonary toxicity of Pam; they merely 
suggest that the potential of most oils to produce a pneumonic reaction 
when aspirate! or administered in the form of nose drops may also be 
present when the oil is presented in aerosol form. In the first patient, 
viral pneumonia and bronchogenic carcinoma with overlying pneumonia 
are likely possibilities. The elderly age of the patient as well as 
the complaint of "hotness on eating" suggest consideration of gastro¬ 
esophageal sphincter incompetence and aspiration while supine. An aspi¬ 
ration pneumonia might be expected to produce a more fulminant reaction, 
however, and the resolution of symptoms and chest radiograph after 
cessation of the aerosolized oil is intriguing. Steroid therapy shortly 
thereafter also complicates interpretation. The oil in the patient's 
sputum is the most helpful finding; this is found in more than 95% of 
, r , . . 68,113 , 
patients with lipoia pneumonia with rare false positives, but 
aspiration cannot be completely excluded. 
There is less information available on the second patient, but the 
story does suggest a lipoid pneumonia which may or may not have been 
due to the patient's frequent use of Pam. It should be noted that the 
patient followed labelled directions incorrectly by spraying into a 
heating, rather than cool pan. Both patients had chronic lung disease, 
mild, and were elderly. Both used thePam spray much more frequently 
than usually expected and the first patient: held the can close to his 
face. These factors may be important in the pathogenesis of this 
hypothetical disease. 
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II. Aerosolized Cooking Oils 
Pam, a product of Boyle-Midway Company, has been on the market for 
about 10 years. The company acquired the brand in 1971 from the original 
marketer at which time they greatly increased advertising and distribution. 
The category of this type of aerosol is in greater demand the past few 
years and, according to Boyle-Midway, Pam is easily the most popular 
n • L 13 
aerosol in its class, with increasing popularity each year. 
Aerosol here refers to a product packaged under pressure and dis¬ 
charged from its container by this pressure. Aerosols contain three 
primary components: propellents, solvents, and active ingredients, as 
well as subsidiary substances such as perfumes, emolients, and flavors. 
Each component may have toxicity for humans. To discharge the contents 
the aerosol container has a hollow dipstick leading to a valve which 
is opened by depressing a nozzle. The propellents are gases at room 
temperature due to their low boiling points, have a high vapor pressure 
which provides propellent force, and are relatively inert, so that 
reaction with other ingredients in the container does not occur. The 
propellents as liquids exert pressure in the container which provides 
the force to drive the contents up the dipstick and out the open valve. 
Upon leaving the container the propellents abruptly becomed gaseous 
and thereby break-up the discharged ingredients and solvents into 
tiny droplets. 
The spray can of Pam when full contains approximately 3% ingredients 
and the rest fluorocarbon propellents (Frecns 11, 12, 114). As the can 
Tradename, E. I. Dupont de Nemours & Company 
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empties the percentage of ingredients increases; fluorocarbons are dis¬ 
proportionately lost in the process of discharging the contents. Fifty 
percent of the ingredients is commercial lecithin and fifty percent is 
soybean oil, a predominantly unsaturated vegetable oil. Commercial 
lecithin is composed of chemical lecithin, (phosphatidyl choline), phos¬ 
phatidyl ethanolamine, and phosphatidyl inositol, (see Figure 1). The 
fatty acid composition of the commercial lecithin and soybean oil used 
in Pam is listed in Table II. 
FDA classifies Pam as a food product; as commercial lecithin is on 
the GRAS list (Generally Regarded as Safe), no toxicological studies on 
the effects of ingestion of this product are necessary. FDA has not 
tested the possibility that this food may be inhaled. The company, Boyle 
Midway, claims to have investigated this likelihood some time ago by 
spraying animals, but they state that the data on this is as yet "unavail 
13 
able." Other products of this type with additional ingredients such 
as artificial flavors and colors are still more suspect as regards pul¬ 
monary effects. If pulmonary disease is associated with use or abuse 
of these oil aerosols, it is not an obvious toxicity: no cases have 
been reported over the years. On the other hand, the sales pattern has 
changed enormously in the last few years and perhaps as more and more 
people are exposed to these aerosols those more susceptible to compli¬ 
cations will appear with evidence of toxicity. 
Other commercial aerosol products have pulmonary effects. Hair 
sprays, associated with a sarcoid-like pulmonary lesion in beauti- 
8 9 34 
cians, ’ 5 caused diminished maximal expiratory flows at low lung 
12r) 
voliimes in non-users upon acute exposure ~ and significantly abnormal 
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82 
pulmonary function tests in beauticians exposed chronically. Ward 
in 1911^^ proposed a relationship between an aerosol deodorant spray 
and a granuloiratous lung disease resembling sarcoid in two young patients. 
Cough, dyspnea, chest pain, and abnormal pulmonary function tests have 
30 
been observed acutely after exposure to an aerosolized starch product. 
Deaths due to pesticide spray inhalation are recorded each year in this 
country. Acute lipoid pneumonitis with abscess formation has been 
reported following aspiration of a drying oil used in commercial enamel 
paint.^ The aerosol toxicity described here has been seen with correct 
product use, outlined in labelled directions. Lipoid pneumonia has 
also been described in a young man who observed cooking fat fires regu¬ 
larly as a restaurant safety inspector. The inhaled animal and vegetable 
. c . 80 
fats were m a submxcronic form in this case. 
III. Experimental Lipoid Pneumonia 
The first reports of lipoid pneumonia, or oil aspiration pneumonia 
as it was then called stem from the 1920's. Even earlier, in 1915, a 
brief study involving insufflation of various substances into the bronchi 
of dogs showed that both lecithin and egg yolk, which contains 8 to 10% 
phosphatides, produced a lobar type of consolidation with fibrin deposi- 
63 ?0 
tion, indistinguishable from lesions due to "avirulent pneumoncocci." 
Lung cultures of the lesions were sterile in four of the six dogs used 
in the lecithin experiment. 
52 
In 1920 Guieysse-Pellissier injected olive oil intratracheally 
into rabbits and dogs and found the alveoli plugged with polymorphonuclear 
leukocytes, eosinophils, and macrophages rich in oil droplets. Corper 
25 
and Freed two years later recorded mild proliferative pneumonitis seen 
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in rabbits and dogs following intratracheal injections of small amounts 
of olive oil and liquid petrolatum, which remained in the lungs for 
months. Chalmoogra oil, highly irritating, produced bronchopneumonia, 
consolidation, and abscess formation, which they attributed to easy 
hydrolysis to fatty acids in the lung. 
65 Laughlen in 1925 reported oil aspiration pneumonia in infants 
and children following nasopharyngeal application of menthol and argyrol 
in a mineral oil base, a common nose drops treatment then for upper res¬ 
piratory infections in children. He produced pneumonic lesions filled 
with oil by injecting 0.5 cc of menthol in abolene, a mineral oil, by 
tracheostomy into rabbits and also by instillation of the same material 
into their nasopharynx. Furthermore, he dyed the mixture with Scharlach 
R, an oil stain, prior to nasal applicaiton and at sacrifice found the 
dye widely distributed in the lungs with large and small droplets within 
alveoli and macrophages. The coalescence of vacuoles within the macro¬ 
phages sometimes produced large clear spaces which pushed the nucleus 
eccentrically and simulated a "signet ring" cell. 
Papers in the next decade primarily concerned experimental work 
and cases in children. In 1927 Pinkerton^ discussed six cases of lipoid 
pneumonia derived from 290 consecutive autopsies of children and adults 
and was able to obtain in all a history of oil use: liquid petrolatum 
nose drops, c:>d liver oil. egg yolk, milk fat, or mineral oil ingestion. 
He observed that certain factors predisposed to the disease: infancy, 
lavage feeding, cleft palate, convulsions, depressed mental status, and 
other neurological problems associated with aspiration. He described 
the pathological sequence as progression of the oil gravity-wise against 
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ineffective ciliary action and without inciting a cough reflex, phago¬ 
cytosis of the smaller oil droplets, and macrophage encirclement of the 
larger oil masses with formation of giant cells and collagen deposition. 
Clearance of the oil-laden macrophages was assumed to be via the lympha¬ 
tics: he found oil in lymph nodes and in one case, the spleen. Removal 
of the oil from the alveoli appeared to be a slow process and a nodular 
fibrotic reaction was considered the final result of continued exposure 
to oily agents. 
87 A year later Pinkerton conducted an investigation of the effects 
of several "sterile" oils injected into the tracheas of puppies and 
rabbits. He stated that animal, vegetable, and mineral oils were asso¬ 
ciated with different reactions in the lung. Vegetable oils, with the 
exception of chalmoogra and peanut oils which caused acute necrosis, 
remained in the alveoli up to 90 days with very little tissue response. 
These mild vegetable oils were iodized popp/ seed and sesame oil, (Lipiodol 
and Iodopin, respectively, used in bronchography), and olive oil. The 
animal oils caused marked consolidation in a few days but seemed to clear 
rapidly leaving scar tissue. The reaction to mineral oil was in between 
these, with gradual formation of giant cells and fibrosis around large 
masses of free oil. A nearly inert, foreign insoluble substance, it 
appeared to be poorly cleared by the lungs. Pinkerton suggested that 
reaction to the oils depended upon the amount of free fatty acids (FFA) 
originally present and the rapidity with which they were formed by 
hydrolysis in the lung. The vegetable oils had very little FFA initially 
and were apparently not hydrolysed before clearance. 
8 3 
Patterson in 1938 studied the effects of vegetable, animal, and 
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mineral oils, saturated and unsaturated fatty acids, cholesterol, and 
phosphatidyl choline when injected intratracheally into rats and rabbits. 
Fifty-nine dajs after a single 1 cc dose of a "watery" alcohol-solubilizi d 
emulsion of lecithin in rats, the lungs showed a marked peribronchial 
cellular response of polymorphonuclear leukocytes and oil-laden macro¬ 
phages, and hyperplasia of peribronchial lymphoid tissue. The fatty 
material was finely emulsified and phagocytized by macrophages in groups 
around the bronchioles. Vegetable oils as a group produced less reaction 
than the others and seemed to be removed rapidly from the lung. Arachis 
and olive oils, however, caused a nodular reaction of oil-filled macro¬ 
phages and the arachis oil was also associated with fibrinous alveolar 
exudate. Patterson essentially agreed with Pinkerton; he concluded that 
the pulmonary reaction to all oils was similar with slow phagocytosis 
and removal by macrophages. He proposed that the slower the clearance, 
the greater likelihood of a foreign body reaction with giant cells and 
fibrosis. The unsaturated fatty acids appeared to be both more finely 
emulsified and more easily phagocytized than saturated ones. Lecithin 
was considered by this author to be "especially potent" in producing 
experimental lipoid pneumonia. 
19 Burrows and Johnston in 1925 injected corn oil, ("mazola"), sub¬ 
cutaneously ir to several animals and observed that the vegetable oil 
was not absorbed. Binet^ working at the same time found that various 
vegetable oils persisted in toto after subcutaneous injection, whereas 
animal oils completely disappeared. He concluded that metabolism of 
these substances in the tissues of laboratory animals was exceedingly 
slow and postulated on the basis of the histological picture that 
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mononuclear digestion of the oil formed the major clearance route. 
Athough the pulmonary toxicity of free fatty acids, with adverse 
effects increasing with degree of unsaturalion, is considered greater 
than that of neutral fat, this concept is borrowed form toxicity studies 
with other tissues and definitive work in the lungs is absent. Effects 
of homologous FFA and neutral fats on pulmonary vasculature have been 
examined in animal models of the fat embolism syndrome, consisting 
classically of the triad of neurologic dysfunction, respiratory insuf¬ 
ficiency, and petechiae in a traumatized fracture patient. Peltier^"* 
in 1956 injected human bone marrow fats intravenously into rabbits 
and observed more acute and severe changes with FFA than with neutral 
fats as determined by LD,-^ and histologic findings. Following 
injection of the neutral fats, (mineral oil, triolein, or human fat), 
the animals died apparently from acute right heart failure secondary 
to obstruction of the arterioles of the pulmonary vascular bed. Fol¬ 
lowing saponified human fat, oleic, linoleic, or linolenic acid injec¬ 
tion, the rabbits died as a result of massive hemorrhage into the 
lung, which Peltier attributed to chemical action of FFA upon capillary 
endothelium, with subsequent exudation and hemorrhage. His results 
6291109 87 
are analogous to those of other workers ’ ’ and to Pinkerton's 
findings with fatty acids in the lungs: tissue toxicity appeared to be 
a function of the degree of unsaturation, that is, their "chemical 
„85 
activity. 
Other investigators have postulated that neutral fat, arrested 
in the pulmonary micorcirculation, is acted upon by lung lipases to 
release high concentrations of FFA which then produce a chemical 
. 
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pneumonitis. ' ’ FFA are toxic to various cells, including erythro¬ 
cytes.^’^ Pulmonary parenchymal tissue, too, is probably more sus¬ 
ceptible to the increased "chemical activity" of unsaturated FFA. 
III. Iodized Vegetable Oils in Bronchography 
Other experimental studies of vegetable oils in the lungs grew 
out of observations that the iodized vegetable oils used in bronchography 
could be retained in the lungs and could cause lipoid pneumonia as 
32 101 
well as an acute reaction to the iodine. First employed in 1922, 
Lipiodol, a 40% iodized poppy seed oil, was initially considered nontoxic 
123 Wright in 1935 reported a case where iodized rapeseed oil had been 
instilled a year prior to death; the oil was seen on chest radiograph 
just before demise and was histologically present in bronchiectatic 
cavities in the area of an obstructing carcinoma. A dense reticulated 
mass formed by many oil-filled phagocytic cells and a granulomatous 
region in the pleura were attributed to retention of the oil. Rabino- 
89 
vitch and Lederer at the same time described the case of an elderly 
man with lipoid pneumonia at autopsy with recent iodized poppy seed 
oil bronchography. Information on mineral oil or other oil use was 
not mentioned. Granuloma formation following Lipiodol bronchography 
14 
was reported following Lipiodol bronchography was reported by Brody 
99 
and Sheldon' in 1943. 
48 Gowar and Gilmour two years before had found many nodules of 
epithelial cells, some with foreign body giant cells, surrounding oil 
droplets in the lungs of rabbits which had received intrabronchial 
20 injections of iodized poppy seed oil. Chesterman produced lipoid 
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pneumonia in cats injected with the same oil. In 1949 Storrs et al 
described a large granulomatous lesion enveloping oil droplets in a 
surgical lung specimen removed three weeks after bronchography with 
Iodochloral (iodized and chlorinated peanut oil). Chemical analysis 
of tissue from the granuloma contained 300 times the iodine content of 
adjacent normal tissue. 
With this evidence of granulomatous reaction to the iodized 
32 
vegetable oils, Dunbar et al in 1959 investigated the fate of Lipiodol 
in 25 rats injected intrabronchially. They used a stain which reacted 
differentially with Lipiodol and found some oil retention, although 
most was cleared by four months, the endpoint of their study. Minimal 
necrosis at one month which resolved by four months and minimal fibrosis 
at four months were noted. They concluded that Lipiodol was not without 
pulmonary toxicity. 
39 Felton in 1953 examined randomly selected, surgically resected 
lungs and lymph nodes from 34 patients who had undergone bronchography 
46 to 1,404 days prior to surgery. Twenty-three of the lungs showed 
residual microscopic oil after differential stain for iodized oil. 
Six of these, (16% of total specimens), had granulomas consisting of 
oil droplets surrounded by epitheloid cells and foreign body giant 
cells encapsulated within fibrous connective tissue. The lesions 
varied from microscopic nodules within fairly normal lung tissue to 
dense granulomas visible grossly as sub-pie iral, well-circumscribed 
firm, yellow-white lesions. No Lipiodol was found in lymphatics or 
lymph nodes and Felton concluded that lymphatic clearance was unlikely: 
dye not involved in the cellular reaction was probably phagocytized 
‘ 
14 
and eliminate! tracheobronchially. Perhaps bronchial obstruction was 
a factor in stboptimal clearance of the oil in the granulomatous lungs. 
It is not known whether the lesions descr.it ad were of any clinical 
significance. 
Reports of granuloma formation following bronchography with 
103 
vegetable oils have continued to appear. The pathogenesis of these 
lesions in humans is ill-defined: animal experiments with the same 
iodized oils have not revealed as extensive lesions. The effect of 
the iodine in addition to that of the oil has not been differentiated. 
The importance of poor drainage and coexisting respiratory disease is 
unknown. Nevertheless, inflammatory reaction to these compounds is 
present in certain individuals, especially when the dye is retained 
for long periods, i.e., months to years. 
V. Clinical Lipoid Pneumonia 
As the above studies reveal, the pathological definition of lipoid 
pneumonia is not a simple one. Type of oi], length and type of 
exposure, and previous or coexisting disease inthe lungs affect the 
pathological findings as well as the clinical picture. Attempts 
over the years have been made to untangle the various clinical pre¬ 
sentations anl correlate them with some sort of pathogenesis, but 
data on the basic mechanisms is lacking. Nothing is known about the 
'mediators' o: inflammatory changes initiated by oils in the lung. 
The disease wis first recognized in infants and children,^5^5^ 
but after numerous autopsy series it became clear that adult cases 
were more common. The incidence of the disease varies, from 41 in 
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3,500 (1%) to 14% of 389 consecutive autopties. 
Ikeda in 1937 ^ and Sodeman and Stuart in 1946 ^ * developed 
criteria for the diagnosis of lipoid pneumonia. They differentiated 
two major types: "infantile," an acute process, from "adult," a chronic 
granulomatous infiltration. Both types could be seen at any age. 
The association of cod liver and other animal vitamin oils which 
produced fulminant disease, with children, and of mineral oil laxatives 
and nose drops which caused often asymptomatic, slowly progressive 
lesions, with adults, led to these misleading designations. The term 
58 
"paraffinoma," employed by Ikeda, described a localized oil granuloma 
nearly always due to mineral oil which was clinically, radiologically, 
and grossly very similar to bronchogenic carcinoma. 
In agreement with animal experiments, animal oils in humans pro¬ 
duce more acute reactions of pulmonary edema and necrosis and even 
104 
extensive fibrosis or death. Mineral oil lesions have been the most 
thoroughly studied. The course here may be subacute, progressive 
and protracted, or marked by recurrent superimposed bacterial broncho¬ 
pneumonias often terminating fatally. Most often it is asymptomatic 
and indolent, or with nonspecific symptoms of dyspnea, cough, chest 
pain, yellow or purulent sputum, hemoptysis, and accompanying low-grade 
104 
bacterial infection. The patient with lipoid pneumonia is frequently 
discovered on routine radiologic examination or at autopsy. Signs if 
present are usually non-specific: rales, wheezing, rhonchi, and areas 
of bronchial breathing and dullness. The radiologic picture is also 
quite varied. Localized density or widespread diffuse interstitial 
appearance ("ground glass") can be seen. 72 As in other aspiration 
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moieties the bases are more often involved and the right greater than 
the left. The localized "paraffinoma" is difficult to distinguish 
from carcinoma of the lung, as mentioned.^ ^ Early diffuse lipoid 
pneumonia is believed to have characteristic linear interstitial 
changes and "acinar consolidations" due to aspirated oil filling 
the fine air spaces.This acinar pattern can sometimes be seen 
in the periphery of consolidated lesions; it is also found in pulmonary 
hemosiderosis, pulmonary alveolar proteinosis, tuberculosis, pulmonary 
edema, and many other conditions. Very gradual change in the radio¬ 
graph over months with radiologic findings out of proportion to the 
clinical presentation is perhaps the only "typical" finding for mineral 
72 
oil pneumonitis. 
Pulmonary function tests in patients with extensive involvement 
demonstrate reduced vital capacity and decreased compliance. The 
restrictive ventilatory dysfunction is due to replacement of air spaces 
26 72 
with fat-laden inflammatory tissue. ’ Bronchography is negative 
unless secondary infection is present. Sputum examination, unstained 
or stained with fat dyes, shows oil-laden macrophages or excessive 
37 free oil. Sputum was positive in 56 out of 57 patients in one 
113 
series and is generally considered to yield false negatives 
extremely rarely. Several early morning collections before mouth 
cleansing or oreakfast and following a few days of fat-free diet is 
37 68 
recommended for highest yield. ’ 
The clinical pictures of lipoid pneumonia can be summarized: an 
acute pneumonitis, often misdiagnosed as acute bronchopneumonia as 
well as exacerbated by superimposed bacterial infection; a chronic 
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granulomatous lesion with cough, chest pain, weight loss, and night 
sweats simulating tuberculosis or carcinoma of the lung; and a very 
slowly progressive, often asymptomatic diffuse interstitial process. 
Chest radiograph, sputum examination, and lung aspiration biopsy are 
the most reliable diagnostic criteria. 
The histopathologic findings associated with these clinical 
descriptions tre similar to those outlined above in animals. Grossly 
the lung is heavy with irregular, often confluent areas of induration 
97 
which are yellow-white if the oil aspiration has been recent. Both 
gross and microscopic appearance may resemble tuberculous caseous 
consolidation or sarcoid granulomas. 
Theories as to why fats seem to produce different reactions in the 
lungs have already been alluded to; the actual pathogenesis of exoge- 
nous lipoid pneumonia is unknown. Pinkerton, Sante, ano others 
believe that the intense acute reaction to animal oils is due to 
their higher free fatty acid content. In addition, their position 
in the alveoli favors oxidation to these, presumably more irritating, 
compounds. Others hypothesize that the more unsaturated, the easier 
lung lipases can hydrolyze an oil to FFA. Animal oils are apparently 
cleared more rapidly by macrophages than mineral oil, which is 
attributed to easy saponification of the animal oils. The problem 
with mineral oil is presumed to be this extremely slow clearance; 
not saponified, it is thought to be undigestable by the phagocytes. 
98 7 2 
Sante and Miller et al attribute both the diffuse interstitial 
lesions and dense consolidations of mineral oil to its physical 
presence: small quantities administered over a long period of time 
' 
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gradually accumulate, providing a nidus foi foreign body reaction, 
and overwhelm the lung by a mass effect. The different distributions 
in the lung a*e related to the different ways mineral oil is admini¬ 
stered and aspirated. 
113 
Volk et al ’ hypothesize that macrophages can disintegrate 
and set free the intracellular lipid droplets. The liberated material 
may then be re-aspirated from the upper bronchial tree, thus producing 
a vicious cycle. According to them, a recycling process could account 
for the chronicity of lipoid pneumonia, in which progression of pulmo¬ 
nary changes is sometimes seen after oral or nasal intake of the lipid 
has been discontinued. 
As regards the vegetable oils, most workers argue that their 
relative lack of toxicity is due to absence of FFA; however, increased 
fatty acid content would be expected with deteriorated oil, as with 
the animal fats. Why certain vegetable oil—chalmoogra, peanut, 
arachis, and occasionally olive—should produce intense inflammatory 
reaction is perhaps a result of particular components, as yet undeter¬ 
mined, of these oils. The combination of fairly rapid clearance and 
slow breakdown may account for the usual mild response. In individuals 
with impaired clearance mechanisms, ciliary, cellular, or obstructive, 
greater toxicity might be expected and possibly this is the case in 
the rare patient who developes lipoid pneumonia secondary to iodized 
vegetable oils. In all the various oils the relative importance of 
lymphatic vs. tracheobronchial clearance mechanisms has not been 
determined. 
Another question has been posed: can chronic pulmonary exposure 
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to mineral or other oils result in neoplasm? Examples of lipoid 
pneumonia simultaneous or adjacent to carcinoma have rarely been 
reported, so a direct etiolcgic relationship is unlikely. 
Evidence does suggest that certain lung carcinomas, especially adeno¬ 
carcinoma, may arise in areas of epithelial proliferation accompanying 
124 
pulmonary fibrosis. Pulmonary fibrosis due to mineral oil could 
thus contribute secondarily to the genesis of malignancy; in one case 
17 
this appeared to be so. This concern is of particular importance 
to workers exposed occupationally to mineral oil mist generated by 
rapidly moving machinery lubricated with oil. More direct complications 
of lipoid pneumonia are fibrosis, contraction and narrowing of the 
bronchial tree, compensatory emphysema, and moderately severe restric¬ 
tive and obstructive ventilatory dysfunction similar to that found in 
chronic bronchitis. 
Treatment of diagnosed lipoid pneumonia consists of discontinuing 
exposure, correction of underlying defects predisposing to or causing 
aspiration, and resection if disabling symptoms persist and disease 
is localized. Most researchers feel that discontinuing oil use leads 
to stabilization and slow resolution of lesions, but residual pulmonary 
72 
fibrosis is not unusual. Prednisone therapy is questionable. Cases 
of histologically demonstrated reversal of lesions following steroid 
4 
therapy are reported as well as unresponsive, ones. 
VI. Surfactant and Endogenous Lipoid Pneumonia 
In addition to soybean oil, Pam contains phospholipids. These 
' 
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same compounds are important constituents of pulmonary surfactant, of 
which dipalmitoyl lecithin (DPL) is the major surface active component.^ 
Phosphatidyl choline in human surfactant is completely saturated,^ 
whereas commercial lecithin is 77.8% unsaturated. 
Endogenous lipoid pneumonia is a rare chronic inflammatory process 
involving a segment or a lobe, secondary to obstruction of a bronchus. 
Alveolar macrophages in this disease, compared with those from control 
patients with non-obstructing endobronchial tumors, are larger, contain 
large, lipid-filled vacuoles with a "foamy" appearance, and upon cultur- 
21 
ing in vitro yield lipid material very high in DPL. Similar material 
is not obtained from cultured control macrophages. Whether endogenous 
lipids are responsible for this disease or macrophages important in 
the normal catabolism of the surface-lining layer of the lung is 
unknown. 
Gross et al~^ injected a small amount of homologous lipid, extracted 
from animal lungs of the same species, into the tracheas of rats and 
guinea pigs: all of the animals exhibited a chronic pneumonitis re¬ 
sembling kerosene inhalation, and several died. No assessment of the 
sterility of the injected material was attempted. 
Early lesions showed proliferation of alveolar cells and reticulin 
with thickening of alveolar walls and obliteration of air spaces. 
These changes progressed at 7 days to diffuse alveolar fibrosis and 
desquamation of ceils in the air spaces. By the end of the second 
week much of the pneumonitis had resolved, though irregular scar-like 
cellular foci remained. At four weeks the lesions appeared fairly 
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uniform from animal to amimal and showed widely separated scars. This 
histology is similar to reactions secondary to heterologous animal fats 
in the lungs, in humans and experimental animals. It is interesting 
to note that no cells with vacuolated cytoplasm, as are customarily 
found in endogenous lipoid pneumonia, were observed with any stain. 
Resolution with mild scarring after one dose might not be seen with 
repetitive doses. 
Before the development of continuous positive airway pressure 
ventilatory devices, much research effort was directed towards develop¬ 
ing aerosolized DPL. In 1964 DPL was administered in microaerosol form 
94 
to infants with respiratory distress syndrome. Synthetic DPL was 
dispersed into water and distributed in particles of mean diameter 
0.25 Mm. The small series yielded equivocal results and research in 
the area was abandoned, but one wonders whether this technique might 
have become an occupational hazard to health personnel in nurseries 
where lecithin micro-droplets were generated. 
VII. Fluorocarbon Propellents 
The fluorocarbon propellents (see Table III) which are responsible 
for aerosol generation in Pam are not without their own toxicity. 
These fluorochlorohydrocarbons are identified by a number following 
the name, e.g.. Freon 114, which designates thenumber of halogen and 
JL 
carbon atoms." Freon 12 was the first to be synthesized in 1930 
• • 
This is the Dupont numbering system. The first digit on the right in¬ 
dicates the number of fluorine atoms, the second digit from the right 
is one more than the number of hydrogen atoms, and the third digit from 
the right, omitted if zero, is one less than the number of carbon atoms 
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by Migdleyand Henne and was introduced as a refridgerant gas less 
toxic via inhalation than sulfur dioxide or ammonia. Aerosol insecti¬ 
cides using Freon 12 were developed during World War II and sold on 
35 
the civilian market by 1947. Since then the uses of cosmetic, 
pharmaceutical, and household aerosols have grown exponentially; in 
1972 the world production, half of it in th United States, of the two 
major gases, Freon 12 and Freon 11, was 0.5 and 0.3 megatons, respec- 
54 
tively. The non-fluorinated aerosol propellents such as propane 
and isobutane are quite flammable and this accounts for much of the 
popularity of the non-flammable Freons. 
OriginalLy the fluoroalkane gases were considered biologically 
inert. In the 1960's reports occurred of sudden deaths among teenagers 
who attempted to "turn on" by inhaling the propellent gases from 
aerosols. The sudden nature of these "sniffing deaths" and the 
lack of autopsy findings implicated a cardiac mechanism, such as an 
arrhythmia, in the pathogenesis. Also during this time were numerous 
reports form the United Kingdom of an increase in sudden, unexpected 
deaths of asthmatics.59,10_>,106 ^fter epidemiological and clinical 
studies the British investigators decided that this excessive mortality 
was due to ventricular arrhythmias following over-use of pressurized 
aerosol bronchodilators. 
Animal studies since then have researched the fluorocarbon blood 
livel at which toxicity, primarily cardiac, occurs. Taylor and Harris 
found that mice pretreated with three breaths of a fluoroalkane gas, 
(Freons 12, 31, or 114), and then exposed to an otherwise well-tolerated 
110 
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degree of hypoxia developed fatal AV block and profound sinus brady¬ 
cardia. In addition, they observed that the hypoxic challenge could 
be given as h te as 15 minutes after the brief exposure to Freon 
with the same cardiac depression, which implied that it was not 
secondary to displacement of pulmonary alveolar oxygen by Freon. In 
their original experiments a bronchodilator was used; since then they 
have obtained similar results in more than 200 mice using eight com¬ 
monly used household and cosmetic aerosols, an aerosol toy, and 
commercially available pure Freons 12, 11, and 114. Similar experiments 
in dogs and monkeys revealed that this toxic sensitization by Freon 
on the heart disappeared more rapidly—in l1^ to 3 minutes—than in 
mice. 
In awake or anesthetized monkeys, inhalation of 30% Freon 12, 9% 
Freon 114, and 61% oxygen caused ventricular premature beats, bigeminy, 
or tachycardia in all, without lowering arterial oxygen tension or pH 
or raising arterial CO^ tension. Kilen and Harris exposed rat left 
ventricular papillary muscle in a well-oxygenated muscle bath to Freon 
12; they observed depression of myocardial contractility which was 
linearly dose-dependent. Freon 12 caused a similar decrease in myocar- 
56 
dial contractility in four human papillary muscles. In dogs and cats 
the arterial blood levels of Freon 12 rose linearly with its inspired 
concentration, while myocardial contractility and arterial blood 
pressure decreased in a dose-dependent fashion, and total peripheral 
54 
resistance declined. Harris and his coworkers conclude that Freon 
12 is directly toxic to vascular and heart muscle. However, the doses 

used were mud greater than those expected to result from usual aerosol 
use. 
Aside from cardiac toxicity, fluorocarbon damage to the lungs of 
experimental animals has been reported by only one group of investiga- 
o o i c: oo AO lie: 
tors, Aviado et al. ’ ’ ’ ’ ’ They find that several propellents, 
including Frecns 11, 114, and 12, can cause changes in pulmonary function 
in rats, dogs, and monkeys. Bronchoconstriction and dilation, decreased 
respiratory minute volume and tidal volume, and increased pulmonary 
resistance are variously observed. The concentrations of fluorocarbon 
used were high: 10% and 20% in air, whereas an asthmatic using a 
a bronchodilator aerosol, for example, would in a single breath inhale 
a concentration of about 2%. An individual spraying Pam for several 
seconds even in a poorly ventilated kitchen would probably not experi¬ 
ence this high a concentration. In addition, many of the numbers 
generated in Aviado's pulmonary toxicity studies, although suggestive 
of a trend, are not significant. There have been a few reports of 
decreased airway conductance in healthy and asthmatic subjects after 
inhalation of fluorocarbons, but these changes have not produced 
symptoms^ ’ or have produced only slight cough and wheezing. 
Experiments with humans, both normal volunteers and asthmatics 
with histories of heavy aerosol use, to determine the peak blood levels 
of fluorocarbons after single breaths, several repeated breaths, and 
single breath;; over a period of hours of commercial bronchodilators 
have demonstrated a wide range of levels ard sparked a lively contro¬ 
ls r * 29,31,76,84,102,119 
versy over the safety of aerosol bronchodilators. 
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Difficulty in interpreting much of the worl. stems from extrapolation 
of levels which cause definite toxicity in experimental animals to 
humans. Also, variation among human subjects in absorption and elimi¬ 
nation of the fluorocarbons—as much as a 120-fold difference 
84 
between two subjects in one study —advises caution in evaluating 
the data. 
Most investigators have found fluorocarbon blood levels in humans 
well below those required for cardiac toxicity in epinephrine-sensitized 
dogs, (e.g., 20-25 ug/ml. Freon 11) after single or a few breaths of 
31 
a bronchodilator. Draffan et al found levels appraching that which, 
in the dog, would be toxic, if the subject inhaled Freon 11 on every 
breath up to two minutes; these 'dog' toxicity levels were not reached 
nor were any sign of cardiac or respiratory toxicity seen. 
102 
A study from Riker Research Laboratories, which has developed 
and marketed several inhalation drugs containing fluorinated hydro¬ 
carbon propellents, found no toxicity in rats, mice, and dogs breathing 
large doses of fluorocarbons except occasional sedation, ataxia, or 
depression, which they attributed to the mild anesthetic properties 
of the propellents in such high doses. The studies varied from two 
weeks to 23 months of daily inhalation doses and hematology, blood 
chemistries, urine analysis, and EKG's (dogs only) were monitored. 
This opposes other animal studies which found significant acute 
cardiac toxicity at equal exposures. 
German workers after thorough studies have classified all the 
commercially used propellent gases according to doses toxic for experi- 
64 
mental animaJs. Inhalation exposures of mice, rats, and guinea pigs 
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to concentrations of 0.5, 1.5, amd 5.0% by volume of mixtures of propel¬ 
lents 11 and 12, two hours a day for 100 days, showed no changes in weekly 
growth, lung histology, or blood parameter< vs. control animals. Con¬ 
centrations of Freons 12 or 114 required to produce anesthesia in rats 
and guinea pigs were extremely high—60% for 60 minutes—and no concen¬ 
tration resulted in death. Propellent 11 caused deep anesthesia at 10%con¬ 
centration for 90 minutes and death at 20% for 5 minutes. These con¬ 
centrations are not achieved when pressurized packs are sprayed; it is 
estimated that discharge of seven and one-half 18 oz. cans in a very 
small non-ventilated room, (176.5 cubic feet), could produce a Freon 
11 concentration of 11%. 
The health branch of Health and Welfare Canada designed a project 
in which 20 white female housewives used a number of household and 
personal aerosols over a four week period and were examined for changes 
in cardiac, respiratory, hematologic, and blood chemistry parameters. 
No morbidity was found and no fluorocarbons discerned in the blood 
sampled at intervals during the study. Two major shortcomings of this 
modest study are fairly obvious; the study covered only four weeks of 
exposure as contrasted with potential years of use, and the women were 
carefully selected for excellent health: none had cardiac or respiratory 
abnormalities by history or function tests and only three smoked. Also, 
no description of space and ventilation characteristics of the home 
environments was given. 
Although studies extending over years do not exist, on the basis 
of available information it is generally accepted that "normal" exposure 
to fluorocarbon propellents is not injurious to health."^ Studies on 
. 
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effects of these gases, adsorbed onto food and ingested, are underway 
at Dupont. On the other hand, the recent reports of the National 
22 
Academy of Science and the Interagency Task Force on Inadvertent 
f) 0 
Modification of the Stratosphere have thrust the issue of direct 
fluorocarbon toxicity aside. 
In 1974 Molina and Rowland^ proposed that fluorocarbons, although 
chemically inert and stable at the lower atmospheric layers of Earth, 
are dissociated by ultraviolet light (190-220 nm wavelength) in the 
stratosphere and produce chlorine atoms which can catalyze the break¬ 
down of ozone to oxygen. The ozone concentration at 20 to 25 kilometers 
up is maximal and acts as a shield against ultraviolet radiation. Excess 
uv radiation causes skin cancer, retards growth in crops, is possibly 
important in climate changes, and injures many forms of life, especially 
micro-organisms. According to Molina and Rowland, most fluorocarbons 
exist in the atmosphere for 40 to 150 years before reaching the 
stratosphere and therefore the quantity of these compounds already 
released into the atmosphere as of 1972 could deplete the ozone layer 
96 7 to 18%, eventually. With the increasing production of aerosols, 
this ozone depletion would become increasingly greater. The National 
Academy of Science estimated that a 5% decrease in ozone could produce 
30,000 new cases of skin cancer per year in the United States, which 
represents and 10% increase. 
The federal government commissioned NAS to study this urgent 
question; time is crucial when dealing with pollution measured in mega- 
22 
tons per year. The report, issued September 19/6, agreed with the 
findings of the Interagency Task Force last June in confirmation of 
I . 
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Molina and Rowland’s thesis and calls for rule-making to restrict 
dissipative uses of fluorocarbons. The same month Congress passed 
the Toxic Substances Control Act, expanding; regulatory authority of 
the Environmental Protection Agency to cover all fluorocarbon use, and a bill 
(H.R. 15759) was proposed in the House to amend theFederal Hazardous 
23 
Substances Act to include aerosol containers which contain fluorocarbons. 
This bill is before the Committee on Interstate and Foreign Commerce. 
Oregon has already banned the sale of fluorocarbon containing products; 
passed early last year, the law becomes effective June 1977. 
Boyle-Midway may be packaging Pam with nitrous oxide, soon. 
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MATERIALS AND METHODS 
I. Preliminary 
Female Hartley short hair, smooth-coated, guinea pigs raised behind 
a "sterile barrier," (i. e., autoclaved materials and food, 10 ppm chlo¬ 
rinated water, strict personal hygiene, 15-20 room air changes per hour) 
were used in all experiments except in II, where guinea pigs raised non- 
sterilely were used. The animals in both short term and long term 
experiments were housed in an all guinea pig room, segregated by 
experimental group, in stainless steel cages with removeable mesh bottoms. 
They were fed Purina guinea pig food and 10 ppm chlorinated water ad 
libitum. Temperature was maintained at 70-72°F with 50% humidity, 12 
hour day/12 hour night photoperiod, and 10-12 room air changes per hour. 
The animal papers beneath the cages were changed daily and the cages 
washed every two weeks. 
Animals were selected for each group and for sacrifice at random. 
Sacrifice was performed with an intraperitoneal injection of 50 mg/kg 
body weight sodium nembutal. The trachea was immediately located and 
48 
ligated to prevent atelectasis and the lungs were gently freed and 
fixed for a minimum of 48 hours in 10% formalin solution. A section 
from each of four lobes was obtained for oil red 0 and hematoxylin/eosin 
staining. The oil red 0 reaction with Pam was checked by spraying Pam 
onto alcohol-c eaned slides; it stained orar.ge-red with the dye. 
Pam packaged in aerosol spray cans for consumers was used through¬ 
out . 
The lack of previous inhalation studies with a commercial oil 
aerosol and also of well-described small animal intubation techniques 
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necessitated development of these in the first few months. Animals 
were sprayed briefly (15 seconds) with Pam, sacrificed immediately, and 
found to have oil-stained droplets in thei ' lungs (see Figure 2). Using 
400 gram female guinea pigs, it was discovered that (1) tracheostomy 
and spraying the aerosol into the tracheostomy needle, (2) intratracheal 
injection of fresh Pam with a high percentage of fluorocarbon propellent, 
and (3) intratracheal injection of the extremely viscous propellent-free 
Pam in any but minute amounts, all produced immediate death. In the 
first two methods, immediate absorption via the lung of a large amount 
of fluorocarbon coupled with anoxia most likely caused cardiac arrhythmia 
and arrest; in the third method, the viscous Pam was observed to remain 
in the trachea in sufficient amounts to cause nearly complete obstruc¬ 
tion. 
The length of spraying and exposure times in the Pam experiments 
was necessarily somewhat arbitrarily determined, but an attempt to 
simulate human experience was in mind. Pulmonary function measurements 
reveal that the tidal volume in guinea pigs weighing from 130 to 940 
grams averages 1.7 mis with range 0.88 to 3.9 mis, the respirations per 
minute 80 (45 - 116), and the minute volume 145 (75 - 362) mls.^ Thus 
in a 15 minute period an animal might inhale from 1135 to 5430 mis; the 
volume of the experimental box was greater by 10- to 50-fold. With a 
3500 to 9000 mis minute respiratory volume, an adult human even in a 
3 
small kitchen of 10 to 12 m would inhale a smaller percentage of total 
room air; however, localized effects by the immediately surrounding 
air may be important here. In any case, most of the aerosolized Pam in 
terms of mass probably settles out quite rapidly; it is the submicronic , 
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respirable particles whose concentration decay with time would depend 
L 
most upon room ventilation characteristics in a 15 minute exposure period. 
Amount of non-gaseous Pam delivered in a 15 second spray averaged 
0.5324 mgm, in fifty 15 second sprays, indicating an average of 0.03% 
(by volume) concentration of fluorocarbons in the plasticene box per 
15 second spray. 
In light of these preliminary findings, and after numerous practice 
intubations in both deceased and alive animals, the following experiments 
were devised. 
II. Pulmonary Function Tests 
Four 600 gram female guinea pigs were given 15 and 30 second normal 
saline aerosol challenges following a 15 minute period of conditioning 
to surroundings in a body plethysmograph designed for guinea pigs. The 
animals then received two 15 second challenges of Pam aerosol spray. 
Flow rates and tidal volumes were recorded by the method of Amdur and 
1 27 
Mead and Dennis et al. 
III. Short Term Exposure Studies 
Eighteen 250-350 gram female guinea pigs were used. Six were 
anesthetized with intraperitoneal sodium nembutal, 20 mg/kg body weight, 
and intubated every other day with a sterile #19 gauge, blunt-ended, 
curved steel needle with removable wire core through which 0.05 cc of 
viscous Pam (after propellents had been allowed to evaporate) was injected 
into the trachea. Six guinea pigs underwent intratracheal injections 
every other day with 0.05 cc sterile normal saline. 
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Six guinea pigs were sprayed simultaneously for 15 seconds with 
Pam four times a day, seven days a week, in a 35.5 x 35.5 x 44.4 cm 
(55,955 cc) plasticene box and allowed to breathe the resulting atmos¬ 
phere for 15 minutes. Unrestrained, the animals’ nostrils were not neces¬ 
sarily directed into the aerosol stream. The spray periods were divided 
over six hours. The plasticene box was cleaned weekly and its absorbent 
animal paper lining changed daily. 
The guinea pigs were housed in the all guinea pig room three to a 
steel cage, transported to the laboratory in plastic cages with sawdust 
bedding, and handled by two people. One guinea pig from each group 
of six was killed 1, 24, and 72 hours and 7, 14, and 21 days after start 
of the experiment. 
IV. Long Term Exposure Studies 
A. Twenty-four 290-320 gram female guinea pigs were used after a 
two week quarantine period. They were housed by groups, originally 
four to a cage, and transported as above. Handling was by four people: 
two in the first half of the experiment and two in the latter half. 
Food, water, and weekly weights were monitored. 
Two groups of four (A,B) were subjected twice a day to a 15 second 
spray in the plasticene box followed by a 15 minute inhalation of the 
resulting atmosphere in the box. The spray periods were three to four 
hours apart, five days a week. 
One group of four (D) was anesthetized and injected intratracheally 
with 0.05 cc sterile normal saline, one dose, and another group (C) was 
anesthetized and injected intratracheally with 0.05 cc Pam after fluoro¬ 
carbon evapoiation, one dose. These two groups were not transported to 
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the lab after the initial intubation. 
Four animals served as a control group* (E) and travelled to and 
from the lab and were handled the same as groups A and B. 
One guinea pig selected randomly from each group was killed at 30, 
60, 130, and 180 days after starting. Blood was obtained for white 
blood cell count (Coulter 'S' Counter) and differential and the lungs 
were weighed. Alveolar macrophages were obtained by the method of Gee 
45 
et al using normal saline lavage fluid and then stained with Wrights 
and oil red 0 for the guinea pigs sacrificed at 180 days only. 
B. Six guinea pigs were used. Two 570 gram animals were anesthe¬ 
tized and injected intratracheally with 0.1 cc normal saline daily for 
four days (H). 
Two 570 gram animals were intubated and injected daily for three 
days with 0.1 cc of an ether-solubilized, water-dispersed solution of 
lecithin (J). This commercial lecithin coarsely grained powder was 
obtained from Central Soya Company, Chicago, which supplies Boyle-Midway 
with the ingredients for Pam, and is (soybean) oil-free, but otherwise 
equivalent to the phospholipids in Pam. It was soluble in few non-toxic 
liquids; after solubilization in ether and dispersion in water, the ether 
was evaporated leaving a watery emulsion of the lecithin, which was 
used for injection. Approximately 6 jag of commercial lecithin was 
injected per dose. 
One 700 gram animal was injected intratracheally \tfith 0.1 cc of the 
propellent-free Pam for four days (F). 
These animals were sacrificed after 61 days and the lungs prepared 
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for histologic examination. 
One 200 gram guinea pig was injected intratracheally with 0.05 cc 
of the propellent-free Pam every other day for a total of 10 doses (G); 
she was sacrificed 193 days after start of the experiment. 
All guinea pigs appeared healthy at time of sacrifice. 
For outline of guinea pig experiments see Table IV. 
Blood agar and Sabaroud's with gentamycin plates, and Brain and 
Dubos broths were innoculated with small amounts of Pam sprayed freshly 
from the can. They showed no growth except for the blood agar plate 
which grew a few colonies of Bacillus species, a non-pathogen (for 
humans) and common contaminant. 
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RESULTS 
I. Pulmonary Function Tests 
There was no change in flow, (volume differentiated with respect 
to time), respiratory rate, or tidal volume after the normal saline 
aerosol challenge or the first Pam challenge in any of the guinea pigs. 
Following the second 15 second Pam challenge decreases in tidal volume 
and flow were observed in three of the four animals, but as there was 
no change in respiratory rate, no broncho constrict ion can be inferred. 
Bronchoconstriction in guinea pigs causes decreased tidal volume with 
increased rate and, if severe, decreased flow. The decreased tidal 
volume and flow seen is most likely due to differences in aerosol 
delivery rate. 
II. Short Term Exposure Studies 
Grossly the lungs of all the animals appeared normal. Histo- 
pathology of the lungs is summarized in Table V. 
Oil droplets lining bronchioles and air spaces were seen in the 
sprayed guinea pigs sacrificed at 1 and 24 hours and 15 and 21 days. 
A few droplets were found at 3 and 7 days, but they were not greater 
in number thai that seen in saline injected controls. Fat in the 
positive lung: was present in large particles measuring up to several 
microns and snail, submicronic particles and was finely emulsified 
within cells, which were predominantly monocytes, in the 15 and 21 day 
animals. The heaviest concentrations of impacted particles were in 
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and around terminal bronchioles and alveolar ducts; many areas were 
devoid of droplets, while adjacent tissue showed significant concen¬ 
trations. Although usually only one or two lobes per guinea pig con¬ 
tained stained material, upper and lower, left and right lobes were 
equally involved overall. The amount of oil in these sprayed animals 
was less than that seen in animals which had received Pam via intra¬ 
tracheal injection, but more than the artifactual material observed in 
saline injected individuals or controls. Artifactual fat droplets 
were large, very round, and above the tissue plane. In all groups 
fat droplets were observed within bronchial cartilage as has been 
6 83 
described in guinea pigs by other workers, ’ and this oil was there¬ 
fore ignored. 
Pam injected animals had oil particles in several or all lobes, 
with distribution similar to that in the sprayed animals. The concen¬ 
tration of oil particles in these injected guinea pigs was the heaviest 
noted in any experimental group. 
The lungs of the saline injected guinea pigs appeared normal upon 
hematoxylin/eosin staining, as compared with controls from the long 
term exposure study. In the animals sacrificed at 15 and 21 days 
after 10 intratracheal injections, mononuclear cells (MNC) were pos¬ 
sibly increased on three and two sections, respectively, but this was 
not considered significant as it was non-fccai and very minimal. 
Animals which received Pam injections, however, demonstrated 
progressive pulmonary changes of focal MNC infiltrates, some near 
terminal bronchioles, atelectasis and extension of focal increased 
cellularity up to 0.5 mm in diameter, and appearance of foamy 
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histiocytic cells in these areas. Eosinophils were found in alveolar 
walls, but were also noted in the saline treated individuals. Many 
giant cells were seen in the guinea pig killed after three Pam injec¬ 
tions (7 days); refractile material was observed in several of these 
upon polarized light examination (see Figure 3). A few foamy giant 
cells were observed in the animal receiving 10 Pam injections (21 days) 
in regions of atelectasis, foamy histiocytes, and possibly increased 
collagen (see Figure 4). Marked hyperplasia of peribronchial lymphoid 
tissue was also seen in this animal. 
The lungs of animals sprayed with the aerosol after 7 days began 
to develop focal pneumonia with infiltration of macrophages and lympho¬ 
cytes into the walls of alveoli and small bronchioles, and atelectatic 
areas (see Figure 5). Foamy histiocytic cells were seen after 21 days. 
Signs of acute infection, including gross lymphadenopathy or 
polymorphonuclear leukocytes in the lungs, were not found in any of 
the animals. 
III. Long Term Exposure Studies 
A. Food and Weights 
The monthly food and water intake per guinea pig and weekly weights 
are given in '’ables VI and VII, and Figures 10-12. The weights of the 
sprayed animais were much lower than those of the controls or intubated 
animals; the numbers of animals were too small for statistical analysis. 
Food and water consumption increased overall as the animals grew, but 
the differences among groups A, B, and E (sprays and controls) and 
C and D (Pam and saline injected) were not significant, (t test for 
/ 
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comparison of means of independent groups). Control animals grew 
according to breeders' expectations.^ 
B. Peripheral Blood and Alveolar Macrophage Examinations 
Peripheral white blood cell count and differential at time of 
sacrifice are listed in Table VIII. Wide variation among controls as 
well as experimental animals was observed and mild peripheral eosino- 
philia was noted in both sprayed and intubated guinea pigs, as compared 
12 
with normal values for germ-free animals. 
Pulmonary lavage cells, (see Table IX), yielded equivocal fat 
staining results, with some cells in all groups positive for small 
amounts of fat. Eosinophils were impressive: 59% and 51% in the sprayed 
animals vs. 1L% in saline and 14% in Pam injected animals. None were 
noted among the control animal's cells. Macrophage morphology was 
unremarkable. 
C. Lungs, Gross 
Grossly the lungs of groups C and D (Pam and normal saline single 
intratracheal injections) and E (controls) appeared normal. The lungs 
of the sprayed groups, A and B, appeared normal also except for mottling 
and scattered petechiae in the (B) 180 day animal, possibly related 
to trauma at time of sacrifice. Lung weights expressed as per cent of 
body weight, (see Table X), were comparable in all the animals and 
also consistent with data elsewhere. 
Of the animals intubated several times, group H (saline) and G 
(Pam) lungs were normal in appearance while the left upper lobe of F 
(Pam) exhibited several pale, raised 1-2 mm diameter areas. The 
lecithin injected guinea pigs’ lungs (J) appeared dark and considerably 
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contracted. 
D. Lungs, Microscopic 
Histologically the lungs from the four control animals (E) stained 
only bronchiolar cartilage fat and rare artifact with the oil red 0 
dye and were normal on hematoxylin/eosin stain except in the 180 day 
animal: here numerous scattered small foci of organized lymphoid tissue 
surrounded by otherwise normal lung were evident in all four sections. 
A few similar foci were noted in the left lung of the 130 day control. 
The saline injected lungs (D) contained no oil droplets in excess of 
control amounts; lung tissue was normal except for occasional very 
small areas of atelectasis in the 130 day specimen. 
The lungs of the single dose Pam injected animals (C) showed 
bronchiolar and alveolar oil droplets at 30, 60, and 130 days, but not 
at 180 days,(see Figure 6). The amount of stainable oil decreased with 
time and the distribution appeared random with respect to lobes involved. 
The variety of size and location of droplets was similar to that seen 
in the short term studies: within terminal bronchi and alveoli and 
finely dispersed within large monocytic cells. The animals which had 
received several Pam injections (F,G) had more oil, in large and small 
particles, remaining after 61 and 193 days than the 130 day single dose 
animal (C), (see Figure 7). Oil was again observed within monocytic 
cells. On hematoxylin/eosin staining the lungs showed borderline to 
absent changes of focal atelectasis and MNC infiltrate in the single 
injected group (C) vs. noticeable changes of this type in the multiple 
dose animals (F,G). Foamy histiocytic cells and occasional small giant 
cells were found in the lungs of guinea pig F, (see Figure 8), and 
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specimens from both F and G contained occasional lipid droplets within 
eosinophic material, filling terminal bronchioles and alveolar ducts. 
Lungs from th^ 60 day single Pam injected guinea pig (C) contained hyper¬ 
plastic peribronchial lymph nodes. 
Lungs from the sprayed animals were normal or demonstrated these 
same changes to a milder degree. They contained very little fat stain¬ 
ing material, although amounts greater than controls were seen at all 
sacrifice points. The fat was primarily located within small bronchi¬ 
oles and occasionally alveoli:fat lined these structures forming rims 
of red material. The lungs were essentially normal after 30 and 60 
days with hyperplastic peribronchial lymph nodes in the 30 day (A) 
animal,(see Figure 9). At 130 days both guinea pigs demonstrated in 
all lobes minimal focal MNC bronchopneumonia with atelectasis. In 
addition to these changes, a few foamy histiocytic cells were also 
present in one of the animals at 180 days. The other animal sacri¬ 
ficed at this time had very minimal focal MNC collections, probably 
within normal limits. 
Lungs from the two lecithin injected animals (J) showed minimal 
focal atelectasis and acute changes of pulmonary edema and hemorrhage 
in the lower lobes, but findings to account, for the marked lung con¬ 
traction observed grossly were not apparen;. Fat stains were omitted 
in this group. 
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DISCUSSION 
These experiments were designed to test for the presence of and 
tissue response to Pam aerosolized cooking oil in guinea pig lungs 
after moderate "normal" use of the aerosol as well as following exces¬ 
sive amounts of the oil introduced into the lungs artificially in an 
attempt to visualize the extreme tissue reaction. 
I. Intubated Animals 
Significant amounts of oil were deposited in these animals, where 
histologic findings of atelectasis and focal MNC infiltrations, and 
foamy histiocytic cells in the animals with greatest exposure to the 
oil were consistently observed as compared with saline injected controls. 
The oil persisted in small but significant amounts up to 57, 130, and 
172 days (guinea pigs F, C and G), after intratracheal instillation 
of 4, 1, or 10 doses, (see Figures 6 and 7). These histological find¬ 
ings and persistence of the fat are in close agreement with the results 
48 
cf Gowar and Gilmour using iodized poppy seed oil in rabbits and 
41 Fried and Whitaker using the same oil in cats. Gowar and Gilmour 
did not note cellular oil or foamy macrophages, as the latter authors 
did and as was seen here. 
These results are in agreement with tie general observation that 
vegetable oils injected into the lungs of v.xperimental animals produce 
a subacute or chronic response, rather than an acute or fulminant 
...... 58,65,83,104 _ , J . . .. 
reaction as with animal oils. Tne marked peribronchial 
cellular response of polymorphonuclear leukocytes described by 
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Patterson after chemical lecithin injection into rat lungs was not 
seen in Pam or commercial lecithin injected groups, although some peri¬ 
bronchial lymphoid hyperplasia, (short tern 21 days, long term (C) 60 
days), as well as numerous oil-laden macrophages were noted, in accor¬ 
dance with his findings. 
It is difficult to correlate precisely the degree of MNC infil¬ 
trate or to determine the time course of the changes, as both variables 
were present simultaneously in the experiments. Also, the methods 
used do not lend themselves to easy quantification: it is impossible 
to say at this stage how much Pam reached the alveoli or bronchi in 
injected or sprayed animals. The amount of Pam eventually reaching 
the parenchyma in the intratracheally injected animals probably varied 
considerably from guinea pig to guinea pig. The greatest changes, in 
terms of extent of infiltrate, were seen in the animals injected every 
other day over a period of 21 days; Pam injected animals (C) in the 
long term study received only one dose of Pam but were all sacrificed 
later than 21 days. Was the oil effectively cleared by 30 days in 
these single dose individuals, or was a single very minute dose of 
viscous Pam insufficient to produce the MNC infiltrate? The latter 
may very well be true, as the guinea pigs injected several times with 
Pam and sacrificed at 61 and 193 days had lioticeable histological 
changes, unlike the single injected guinea pigs after 60 days. 
In the short term injected animals changes increased markedly 
with time, but so did the total quantity of Pam introduced into the 
lungs. The theory that vegetable oils maintain their relatively non¬ 
toxic status by efficient pulmonary clearance before problems of 

A3 
obstruction, foreign body reaction, or degradation to more harmful 
components, i.e., unsaturated FFA, can occur suggests that changes 
observed in the short term animals reflect their attempts to handle 
repetitive small doses delivered over an exposure period too brief 
for complete clearance. In patients with chronic bronchitis, COPD, 
heavy smoking history, or other conditions associated with altered 
mucociliary clearance, frequent exposure to an amount of oil handled 
adequately in a single dose could swing the delicate balance in these 
individuals from chronic to acute disease. 
Even in these guinea pigs, exposed artificially to a relatively 
large quantity of Pam — although most of the oil did not descend past 
the trachea — no fibrosis or granuloma formation was seen. However, 
these were healthy animals, apparently able to mobilize the foreign 
oil: the amount of oil in the lungs of single dose guinea pigs decreased 
from 3 (30 and 60 days) to 1 and absent (130 and 180 days). 
II. Sprayed Animals 
Changes found in the animals sprayed four times a day, (short 
term), and two times a day, (long term), for 15 seconds were similar 
and milder in degree than the changes described above in intratrache- 
ally injected animals. The sprayed guinea pigs' lungs demonstrated 
focal MNC infiltrates and atelectasis, (3 short term, 5 long term 
animals), and vacuolated histiocytic cells, (1 short term, 1 long term 
animal). Increased changes followed increased daily exposure: the 
findings were greater in the animals sprayed four times a day in the 
short term study than in the long term study with two daily sprays. 

44 
Possibly the animals chronically exposed to the oil for months adapted 
with improved clearance mechanisms, or perhaps two sprays daily of 
Pam could be handled adequately whereas twice this exposure could not. 
Shoshkes et al,"^^ studying oil deposition in mice after short 
and long term inhalation of aerosolized mineral, com, peanut, and 
motor oils with mean particle size 2.5 pm, found considerable alveolar 
and terminal bronchiolar oil after 48 to 108 hours of exposure over 
14 to 30 days. The spray periods were much longer — hours of exposure 
at a time — than the 15 second sprays used here, so that the animals’ 
usual pulmonary clearance mechanisms were probably overwhelmed. They 
observed the com oil series of lungs to retain the least amount of 
oil; except for a slight increase diffusely in the number of macro¬ 
phages, no inflammatory changes were attributed to the oil. They 
believe that this lack of pulmonary reaction is due to rapid clearance; 
in the Pam experiments, short exposure periods of 15 seconds probably 
allowed the oil to be effectively cleared by time of sacrifice. 
Pam was observed within small bronchioles immediately after expo¬ 
sure; the oil was found within alveoli and cells on later examinations. 
The particle size distribution of aerosolized Pam is not known, ac- 
13 
cording to the company, nor would it be easy to determine. Measure- 
38 95 
ment techniques are complex ’ and as the can empties not only does 
the percentage of oil in fluorocarbon increase, but oil coating the 
discharge apparatus changes the physical characteristics of the aerosol 
generator. /Iso Pam, being hygroscopic, absorbs water in the upper 
respiratory tract and therefore its site of deposition will depend on 
its growth ir size. 
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"Aerodynamic filtration"^ is an important defense mechanism of 
the lung whereby particles larger than 10 ym and smaller than 0.5 ym 
are effectively removed. Most large particles, greater than 10 ym in 
diameter, deposit in the nasal cavity or impact at the carina or within 
the first two bronchial divisions. Particles in the range of 0.2 to 
0.5 ym sediment in later bronchial divisions and the alveoli and are 
93 
capable of producing a tissue reaction. Still smaller particles 
settle by diffusion in the alveoli and are cleared systemically. How¬ 
ever, even large particles of oil, depositing in the mucous-covered 
ciliated epithelium of the nose, pharynx, and bronchioles, may be 
1 O I 
important. Experiments with rabbit and human ciliated sinus epi¬ 
thelium have shown that oil mixtures, (mineral oil), interfere with 
88 
ciliary streaming and are propelled very little, if at all. Other 
agents, such as carbon dioxide, cigarette smoke, alcohol, and possibly 
79 
sulfur dioxide, are ciliotoxic and may further inhibit transport of 
a substance out of the lung. Oily nose drops probably reach the lung 
via retrograde pooling due to ineffective ciliary function, as may 
oils that have been introduced into the mouth. 
The tiny cellular oil droplets seen in the Pam experiments are 
consistent with macrophage ingestion and clearance from the alveoli 
and terminal bronchioles. This is the accepted theory for the fate 
of all fat not expectorated and is in agreement with Patterson's 
observations of "finely," as opposed to coarsely emulsified oil in 
cells following phosphatidyl choline and vegetable oil injections into 
rabbit lungs, which he attributed to easier emulsification of the 
83 
unsaturated cils. 
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III. Poor Growth of Sprayed Guinea Pigs 
In absence of apparent illness, growth of the long term sprayed 
guinea pigs vs. controls and breeders* normal values was remarkably 
poor despite nonsignificantly different food and water ingestion and 
identical handling. Growth in guinea pigs is affected by many nutri- 
12 
tional factors and depressed in acute or chronic infection and ciga¬ 
rette smoke irhalation exposure.^ Evidence for acute infection was 
absent as judged by WBC count and differential, absent lymphadenopathy, 
and lung histology. Guinea pigs grow well on diets with a wide range 
of fat intake and in fact require small amounts of unsaturated fat, 
12 (e.g., 7.3% corn oil), for best growth. Therefore ingestion of Pam 
licked from the fur would not be expected to affect weight gain 
adversely. 
Chronic exposures to considerably higher concentrations of fluoro¬ 
carbons has not produced poor growth in a number of laboratory animals, 
including guinea pigs. ^ >102 p0ssj[gpe that the daily psychological 
trauma of being "sprayed" may have interfered with the animals* diges¬ 
tion although signs of malabsorption in feces were not noted and the 
loud noise of the aerosol discharging was heard essentially equally 
by the parallel control animals. 
Weights of the guinea pigs injected with normal saline (D) were 
somewhat greater than those of Pam injected animals (C), but the dif¬ 
ference was not consistent and may not have been related to pulmonary 
presence or absence of Pam in the lungs, particularly as exposure to 
the oil was a single dose at the start of the experiment and histological 
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changes were minimal. 
IV. Possible Pathogeneses 
The described results may reflect guinea pig response to aspirated 
phospholipid/soybean oil or a coincidental reaction to undetermined 
stimuli. Fluorocarbons are very unlikely to be important here in light 
of extensive chronic inhalation literature documenting their lack of 
pulmonary toxicity in many laboratory animals. Acute or chronic 
"spontaneous pneumonitis," not directly associated with an etiologic 
agent, usually localized to one or rarely two lobes and containing 
predominantly intralveolar polymorphonuclear leukocytes or closely 
packed monocytic cells, is a problem frequently encountered in colonies 
92 o) 
of guinea pigs. According to Richardson, this mandates consistent, 
widespread abnormalities compared with simultaneous controls if reli¬ 
able conclusicns are to be drawn. The controls here did not exhibit 
spontaneous pneumonitis; the individual at 180 days demonstrated a 
phenomenon unique to guinea pigs termed pulmonary perivascular lymphoid 
nodules, reported in 14 to 85% of animals including one "germ-free" 
12 guinea pig, analogous to the animals used here. Whether this finding 
is normal or a response to chronic low-grade infection is not known. 
White blood cell counts and differentials in the long term study were 
within normal limits for germ-free animals, who tend to have lower 
counts and moie polymorphonuclear leukocytes than conventional animals. 
Streptococcus infection in guinea pigs is the only common infection in 
which the animals continue to appear healthy; however, this infection 
12 
usually produces prominent cervical lymphac'enopathy , not noted here. 
12 
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It is difficult to determine with the small numbers of animals 
used whether the mononuclear bronchopneumonia and focal atelectasis, 
which were the most common findings in Pam sprayed and intubated groups, 
are examples of this frequently encountered pneumonitis or a reaction 
to inspired Pam. The observed changes were not confined to one or two 
lobes and the animals referred to by Richardson were not raised "sterilely' 
as they were here,which may be significant. In addition, the changes 
appeared to be progressive, which lends greater weight to their presence. 
Therefore, despite Richardson's caution, it would seem that the his¬ 
tological differences between control and experimented groups are real. 
The changes most likely represent pulmonary response to a relatively 
non-irritating oil: emulsification, engulfment by macrophages, saponifi¬ 
cation and digestion within cells, and lymphatic or tracheobronchial 
clearance with ingestion or expectoration. Greater quantities of fat 
in the parenchyma seemed to produce more intense MNC inflammatory response 
The giant cells noted in three intratracheally injected guinea pigs 
raises the question whether granuloma formation and fibrosis might have 
resulted with use of larger doses or less healthy animals. Giant cells 
in one of these animals contained refractile material, possibly a result 
of contamination during intubation; neutral fat was observed to contain 
anisotropic crystals, (refractile with polarized light), in one study 
48 
of pulmonary response to oils. MNC inflammatory process in the guinea 
pigs did not progress after exposure to the oil ceased, in agreement 
with other vegetable oil studies. 
The relationship of chronic lung disease to the effects of nor¬ 
mally easily handled foreign substances in the lung is important. If 
giant cells, granulomas, or fibrosis are seen only when vegetable oils 
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remain in the lungs for a long time, as experimental workers using 
iodized vegetable oil have suggested,^»^3 then conditions that pre¬ 
dispose to poor clearance, such as chronic bronchitis or cigarette 
smoking, may be necessary for tnese more impressive histological find¬ 
ings to appear. This hypothesis cannot be tested in young, healthy, 
germ-free animals. 
The eosinophilia discovered upon pulmonary lavage of the 180 day 
animals suggests a hypersensitivity reaction. The percentage of eo¬ 
sinophils observed in the sprayed guinea pigs was four times that of 
the Pam and saline injected individuals, possessing normal lung histo¬ 
logy; no eosinophils at all were noted among the control animal’s cells. 
Hypersensitivity reactions to injected and inhaled antigens are well- 
studied in the guinea pig.33,46,72,73,92,118 Eosinophilia is a promi¬ 
nent response to antigenic stimulation via injection into the foot pads 
47 66 67 
or peritoneal cavity of these animals. ’ ’ Eosinophilic response 
in nearby lymph nodes is specific for injection of antigen into foot¬ 
pads. ^ However, injection of normal saline into the peritoneal cavity 
yields fluids rich in eosinophils, although the total numbers are less 
47 
than when antigen is injected. Increased numbers of eosinophils are 
found in guinea pig lungs following parenteral sensitization and sub¬ 
sequent aerosol challenge with a variety of antigens. Thus it is not 
absolutely clear in guinea pigs whether the appearance of eosinophils 
signifies an immunologic process or non-specific irritation. 
The majority of lipids known by serologic tests to be antigenic 
are incomplete antigens, or haptens; they induce antibody production 
90 
only if injected in combination with a heterologous carrier protein. 
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Cardiolipin, the reagin responsible for the Wasserman serological test 
for syphilis, and Forssman haptens are examples of lipid antigens. 
Only phosphat: des and glycosphingolipids aie known to function as hap¬ 
tens. After repeated intravenous injection of phosphatidyl inositol 
and carrier protein methylated bovine serum albumen (BSA), rabbits 
produce antibodies. This hapten is immunogenic only if the injected 
lipid suspension contains lecithin or lecithin and cholesterol in 
addition to the carrier protein; resulting antibody is directed against 
phosphatidyl inositol alone. This requirement for "auxiliary lipid" 
is seen with many other lipid antigen systems. An antibody response 
can be elicited in rabbits by phosphatidyl inositol oligomannosides 
7 8 
even without carrier protein if administered with incomplete adjuvant. 
As regards cellular, or delayed type hypersensitivity (DTH), Coon 
and Hunter^4 discovered in guinea pigs that BSA conjugated with dodeca- 
noic acid, a saturated straight chain fatty acid present normally in 
mammalian tissues, without adjuvant stimulated sustained DTH but no 
detectable antibody production, whereas large amounts of antibody, 
but no detectable DTH, resulted from injection of BSA alone without 
adjuvant. Dodecanoic acid alone is not antigenic, nor does it serve 
as a hapten when conjugated with other materials, or as an adjuvant 
when mixed wi ;h protein antigens. 
One could speculate that oils would be excellent media for the 
transport of lust particles, food, micro-oiganisms, toxic gases, and 
radioactive substances into the respiratory tract. The commercial 
lecithin in P im contains phosphatidyl inositol and ethanolamine as 
well as lecithin; if heterologous protein were carried with these 
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phospholipids into guinea pig lungs, a hypersensitivity reaction could 
result. Pam contains minute impurities, including 26.2 ppm aluminum, 
67 ppm iron, 10.0 ppm boron, 0.5 ppm copper, 12.2 ppm zinc, and 1.0 
ppm manganese, due to processing and is packed in an aluminum can. 
Soybean oil when containing phospholipids is known to absorb signifi- 
+2 +3 
cant amounts of metal cations, (e.g., Zn , Fe ), from ordinary 
69 
water. Although both zinc and aluminum are associated with granulo- 
114 
matous lesions in the lungs, it is doubtful that these elements are 
present in sufficient quantity in Pam to produce hypersensitivity. 
74 92 
DTH in guinea pigs in response to aerosolized PPD, ’ asobenzene- 
XT , 92 n £ . 118 t 
arsonate-N-acetyltyrosxne, Micropolyspora faenx, potassium dichro- 
73 
mate, and Candida albicans has been studied. Richardson has carefully 
examined Types I, III, and IV immunologic reactions in guinea pigs 
following inhalation of aerosolized antigen with previous parenteral 
92 
sensitization. He found acute asthma and eosinophilia of bronchioles 
in Type I (anaphylactic) reactions, hemorrhagic pneumonia and vascu¬ 
litis in Type III (immune complex) reactions, and mononuclear infil¬ 
tration, primarily by macrophages and lymphocytes, of alveolar septi 
and air spaces in Type IV (DTH) reactions. In addition to these MNC 
changes, parenchymal eosinophilia and neutrophilia characterize DTH 
118 following inhalation of Micropolyspora anti gens. 
Skin test results with Pam as well as serologic evidence of anti¬ 
genicity would be helpful in establishing vhether the phospholipid/soy¬ 
bean oil stimulated a hypersensitivity response. The relative lack 
of findings in the two groups with the greatest exposure frequency, A 
and B, with 255, 15 second Pam sprays and fewer pulmonary changes than 
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in the animal::: sprayed twice as frequently for only three weeks, is 
against this theory unless a mechanism for tolerance is postulated 
also. Despite these concerns of an immunologic reaction to foreign 
proteins, simple chemicals, metal ions, and lipids, it seems more 
likely that the histological findings, if not the remarkably poor weight 
gain, of the Pam exposed guinea pigs are attributable to foreign body 
reaction and gradual mobilization of the oil from the lungs. 
V. Problems with the Animal Model; Future Studies 
Guinea pigs were chosen for this study because of their low cost 
and easy care and the availability of germ-free strains, a device to 
accurately calculate pulmonary function measurements, and literature 
on previous inhalation studies. Nevertheless, certain problems arise 
when using these animals. The dimensions of alveoli and terminal 
bronchioles in guinea pigs and man are comparable upon light micro¬ 
scopic examination, but whether cellular responses to various stimuli 
are also alike is not known. Guinea pigs as with all rodents are obli¬ 
gate nose breathers; in addition, their airway dimensions are naturally 
much smaller chan those in man, which may alter the favored deposition 
sites for particles. In mice, fates for each particle size resemble 
that in humans. As mentioned before, young, healthy guinea pigs 
are not analogous to humans compromised by chronic lung disease or 
other problems. Although an attempt to simulate human exposure was 
made, particularly in the long term sprayed groups, analogy with human 
"normal" use remains qualitative rather than quantitative. 
Interpretation of the results is primarily limited by the small 
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numbers of experimental animals, with only one or two to a group. 
Within these limits, chronic exposure of up to 6 months to brief sprays 
of the aerosolized lipid Pam did not cause overt disease in guinea 
pigs, but was associated with poor weight gain and histologic changes 
in the lungs. Fat droplets penetrated in small amounts to alveoli 
following inhalation of the aerosol and in somewhat larger quantities 
after injection of oil into the trachea. Both methods produced focal 
MNC infiltrates, atelectasis, and foamy histiocytic cells, with the 
greatest changes associated with repetitive exposure over a two to 
three week period. 
These results indicate the need for further examination of the 
fate of this aerosol product. Inhalation experiments, both chronic 
and acute, with dogs or primates, possessing a tracheobronchial tree 
more like that of humans, perhaps employing a radiopaque iodized form 
or radioactively-labelled form of the oil for more precise localiza¬ 
tion, could better approximate the problem of whether aerosolized oil 
reaches the alveoli in humans and if so, where it goes. Long term 
inhalation studies with larger numbers of laboratory animals and careful 
monitoring of food, weight, and blood parameters is needed to disprove 
or confirm and explain the disparity in growth between exposed and 
control animals seen here. In addition, skin tests for DTK to the 
sprayed oil, repeat pulmonary function measurements after chronic ex¬ 
posures to the aerosol, and pulmonary lavage for cells at numerous 
points during exposure studies should be performed. 
It is important to pursue the possibilities of pulmonary toxicity 
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with Pam as well as with other cooking oil sprays and household aero¬ 
sols of this too rapidly proliferating market. Aside from fluorocarbon 
propellents, manufacturing companies and FI A have ignored the potential 
inhalation toxicity of aerosol ingredients and have instead concen¬ 
trated on cutaneous, ocular, and gastrointestinal reactions. This 
could be a serious oversight: the ubiquitous aerosol spray can must be 
considered a device for spraying potentially dangerous substances into 
our air and into our lungs. 
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SUMMARY 
Two cases of possible lipoid pneumonia associated with use of 
Pam cooking oil aerosol are presented and the product's components, 
soybean oil, phospholipids, and fluorocarbon propellents, discussed. 
Literature is reviewed concerning the effects of various oils on 
the lungs, in animal experiments and human cases; vegetable oils are 
observed to produce a milder reaction than animal or mineral oils. 
Vegetable oils appear to be important clinically in rare granulomatous 
reactions following bronchography with iodized oil. Exogenous and 
endogenous lipoid pneumonia, surfactant phospholipids, and commercial 
aerosol known pulmonary complications are also discussed. 
Guinea pigs were sprayed (15 seconds) and injected intratracheally 
(0.05 or 0.1 cc) with commercial Pam in short and long term exposures 
up to six months. An attempt to simulate chronic human "normal" expo¬ 
sure was made in the long term sprayed animals. Growth of these 
animals was much slower than that of controls, with nonsignificantly 
different food and water ingestion. Lung weights per body weight were 
comparable. 
Fat droplets were demonstrated in the lungs in widely varying 
amounts and sizes, from several microns to submicronic in diameter. 
Focal MNC infiltrate, foamy histiocytic cells, and occasional giant cell, 
were noted; taese changes correlated with Increased exposure in sprayed 
and injected animals. Signs of acute infection were absent. The chro¬ 
nology of the lesions after exposure to the oil was not determined, 
but it appeared to resemble the chronic processes reported by other 
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researchers working with vegetable oils: several days were required 
before significant cellular infiltrate was evident. 
Marked eosinophilia of pulmonary lavage cells was noted in animals 
sprayed for six months vs. controls. The potential for lipid aerosol 
induced pulmonary hypersentivity reaction is discussed. The histological 
findings are attributed, rather, to foreign body reaction and pulmonary 
clearance of the oil. 
Future studies to confirm or disprove these findings, limited by 
the small numbers of animals and choice of guinea pig for model, and to 
determine their significance for humans are suggested. 
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Table I. Aerosolized Cooking Oil Products 
brand company ingredients 
Pam 
Golden Touch 
Cooking Ease 
Mazola No Stick 
Boyle-Midway 
Boyle-Midway 
Chlorox 
soybean oil, lecithin, fluorocarbon 
propellents 
corn oil (6%), lecithin, artificial 
flavor, isopropyl citrate, methyl 
silicone, artificial color, nitrous 
oxide propellent 
vegetable oils (30%), lecithin,butter 
flavor, -carotene, propellent 
Best Foods mazola corn oil, lecithin, artificial 
flavor, propellent 
Table II. Pam Fatty Acid Composition'*''*''*' 
soybean oil commercial lecithin 
C16:0 10.3% 16.4% 
o
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4.4 5.9 
Total saturates 14.7 
C18 :1 
24.5 16.9 
C
N
 
00
 
i—1
 
u
 
53.8 54.1 
C18:3 
7.0 6.8 
Total unsaturates 85.3 
Unsaturated:saturated 5.8:1 3.5: 
pH 6.7 - 7.1 (1% in distilled water) 
Table III. Fluorocarbons in Pam 
Low pressure propellents 
Trichlorofluoromethane 
Dichlorotetrafluoroethane 
High pressure propellents 
Dichlorocifluoromethane 
boiling pt. 
Freon 11 C C1„F 23.8°C 
Freon 114 C C1JF -C Cl F2 3.8 
Freon 12 C Cl^ 
-29.8 
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Table IV. Outline of Guinea Pig Experiments 
Short Term Exposure Studies 
Sprayed: four 15 second sprays Pam daily (6) 
Pam: 0.05 cc propellent-free Pam injected intratracheally every 
other day (6) 
Saline: 0.05 cc normal saline injected intratracheally every 
other day (6) 
Animals sacrificed after 1, 24, 72 hours; 7, 15, 21 days 
Long Term Exposure Studies 
Group E: controls (4) 
Group A: sprayed with Pam 2 times daily, 5 times per week, for 
15 seconds (4) 
Group B: animals treated as group A (4) 
Group C: intratracheally injected 1 time with 0.05 cc propellent- 
free Pam (4) 
Group D: intratracheally injected 1 time with 0.05 cc normal 
saline (4) 
Animals sacrificed after 30, 60, 130, 180 days 
Group H: intratracheally injected daily with 0.1 cc normal 
saline for 4 days (2) 
Group J: intratracheally injected daily with 
solution of chemical lecithin for 3 
0.1 cc "watery" 
days (2) 
Guinea Pig F: intratracheally injected daily with 0.1 cc propel¬ 
lent-free Pam for 4 days 
Animals sacrificed after 61 days 
Guinea Pig G: intratracheally injected every other day with 
0.05 cc propellent-free Pam to total 10 doses 
Animal sacrificed after 193 days 
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Table V. Histopathology 
SHORT TERM Oil Droplets Hematoxylin/Eosin 
//Doses/Sacrificed (+ to -H- -)__ 
Saline Injected 
1 1 hour - WNL 
1 24 - WNL 
2 72 - WNL 
3 7 days - borderline increase MNC, diffuse, probably WNL 
7 14 +/- WNL 
10 
Pam 
21 
Inj ected 
borderline increase MNC, diffuse; probably WNL 
1 1 hour +++ slightly increased MNC,diffuse; probably WNL 
1 24 +-H- few areas focal MNC infiltrate, lower lobes; 
lipid vacuoles in bronchioles 
2 72 ++ few areas focal MNC infiltrate, all lobes 
3 7 days ++ more areas MNC infiltrate, large FB type giant 
cells, all lobes 
7 
10 
14 
21 
Sprays 
+++ 
++++ 
focal MNC infiltrate, vacuolated histiocytic 
cells, all lobes 
exacerbation of 14 d. with a few small foamy 
giant cells; hyperplasia of peribronchial 
lymphoid tissue 
1 1 hour +++ WNL 
4 24 + WNL 
12 72 + WNL 
28 7 days + focal MNC infiltrate, atelectasis, vacuolated 
histiocytic cells, all lobes 
56 14 ++ few areas focal MNC infiltrate 
76 21 +++ focal MNC infiltrate, greater than 7 d.; some 
atelectasis 
LONG TERM 
Controls E 
30 days 
60 
130 
180 
Sprays A 
43 30 days 
86 60 
195 130 
255 180 
WNL 
WNL 
+/- occasional perivascular lymphoid nodules, 
left lung 
numerous perivascular lymphoid nodules, showing 
organization, all lobes 
+ few areas small focal MNC infiltrate; hyper¬ 
plastic peribronchial lymph nodes 
WNL 
+/- focal MNC infiltrate and atelectasis, all 
lobes 
+ focal MNC infiltrate, atelectasis, vacuolated 
histiocytic cells, all lobes 
1 
- 
60 
Table V. Histopathology, continued 
Sprays B 
43 30 days +/- WNL 
86 60 +/- few areas atelectasis LUL, RLL; probably WNL 
195 130 + few areas focal MNC infiltrate, atelectasis, 
all lobes 
255 
Pam 
180 
Injected C 
++ occasions] focal MNC infiltrate 
1 30 days +++ diffuse increase MNC; probably WNL 
1 60 +++ hyperplasia peribronchial lymph nodes 
1 130 + few areas atelectasis right lung; WNL 
1 180 
Saline Injected D 
few areas focal MNC infiltrate, atelectasis 
LUL; probably WNL 
1 30 days - WNL 
1 60 - WNL 
1 130 — few areas atelectasis lower lobes; probably 
WNL 
1 180 - WNL 
Saline 
4 
Injected H 
61 days areas of etelectasis 
4 61 - WNL 
Pam 
4 
Inj ected 
(F) 61 days ++ focal MNC infiltrate left lung. few small 
10 (G) 193 ++ 
foamy giant cells; lipid vacuoles within 
alveoli 
few areas focal MNC infiltrate, atelectasis 
Lecithin J 
3 61 days (not done) 
lef t lur.g 
pulmonary edema and hemorrhage, loss of 
3 61 11 
alveoli; lungs congested 
congestion, rare areas of pulmonary edema; 
most of lung WNL 

Table VI. Long Term Exposure: Food and Water Intake 
FOOD (mls/month/guinea pig) 
MONTHS 1 2 3 4 5 6 
Controls E 1380 1258 1425 1625 2800 3100 
Sprays A 1144 1241 1460 1538 2583 2300 
tl B 1325 1271 1513 1363 2000 2500 
Pam Inj ected C 912 1050 1520 1355 1567 2400 
Saline Inj ected D 745 966 1570 1795 1783 2800 
WATER (mls/month/guinea Pig) 
Controls E 4605 4850 4900 3825 9643 10250 
Sprays A 4375 5167 5450 4363 9950 9650 
II B 4808 5134 5000 4350 7515 6150 
Pam Injected C 3516 3467 4775 4270 5040 4100 
Saline Inj ected D 3444 3226 4540 4363 4342 4500 

Wk 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
62 
VII. Long Term Exposure: Weekly Guinea Pig Weights 
Controls E Mean Sprays A Sprays B Mean 
305 312 302 291 303 324 334 290 274 338 320 327 308 314 
377 381 383 374 380 329 361 303 299 408 359 338 341 342 
395 393 404 372 391 348 382 311 317 418 373 349 348 356 
472 260 485 437 464 397 420 351 352 472 385 392 403 397 
504 507 531 514 424 452 372 502 415 437 434 
548 526 563 546 456 465 408 529 449 469 463 
569 549 58 V 568 488 509 419 577 483 508 497 
576 580 609 588 512 534 442 608 525 534 526 
612 662 637 488 523 588 484 521 
635 692 664 534 565 639 583 580 
654 732 693 496 538 649 598 570 
698 758 728 556 553 665 612 597 
710 675 693 548 538 687 623 599 
650 708 679 567 562 648 566 586 
673 728 701 557 560 727 575 605 
688 816 752 603 565 675 654 624 
740 832 786 630 652 730 676 672 
865 865 684 701 693 
854 854 670 705 688 
895 895 670 691 682 
887 887 675 712 694 
875 875 706 691 699 
899 899 700 717 709 
919 910 707 698 703 

Wk 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
63 
VII. Weekly Guinea Pig Weights, continued 
Saline Injected D Mean Pam Injected C Mean 
302 343 2S9 305 312 323 341 304 335 326 
390 419 396 388 398 419 461 419 454 438 
466 460 460 430 454 474 428 489 504 474 
467 489 477 426 465 472 441 494 575 496 
503 523 513 457 499 525 436 545 557 516 
542 561 554 552 563 588 599 583 
485 429 448 487 572 605 615 597 
533 550 585 556 596 601 613 603 
610 583 597 583 610 597 
703 648 676 581 526 554 
693 666 680 593 543 568 
686 673 680 590 540 565 
701 643 672 621 586 604 
704 783 744 661 579 620 
819 830 825 710 651 681 
814 850 832 722 680 701 
819 790 805 743 717 730 
791 761 
766 760 
793 759 
812 780 
846 785 
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Table VIII. Long Terra Exposure: WBC and Differential 
30 Days WBC 
JO 
J° g ^ * V ♦Y O c> 
'o V ^ dr 
Cn 
Oy O 
Control E 3,700 37 3 55 3 2 
Sprays A 2,600 32 2 53 4 9 
" B 5,900 46 3 49 0 4 
Pam Injected C 2,100 32 1 60 2 4 1 
Saline Injected D 5,000 43 2 51 2 2 
130 Days 
Control E 2,200 39 2 53 4 2 
Sprays A 1,400 64 1 31 1 3 
" B 2,300 43 2 50 5 0 
Pam Injected C 5,800 34 4 57 3 1 2 
Saline Injected D 3,400 30 2 53 5 10 
180 Days 
Control E 2,600 38 3 56 2 1 
Sprays A 2,200 25 3 65 1 4 2 
" B 3,700 43 0 48 1 3 2 
Pam Injected C 4,000 28 1 62 4 4 1 
Saline Injected D 3,100 63 1 30 3 0 3 
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Table IX. Long Term Exposure: Pulmonary Lavage for Cells in 180 
Days Guinea Pigs 
Wright’s Sta in Qj y / 
Control E 99 1 
Sprays A 35 59 12 3 
tf B 38 51 2 9 
Pam Injected C 78 14 8 
Saline Injected D 83 11 5 1 
Oil Red 0 Stain Fat Droplets (+ to -H-H-) 
Control E + 
Sprays A + 
" B ++ 
Pam Injected C + 
Saline Injected D + 
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Table X. Long Term Exposure: Lung Weights 
30 Days body weigh^ramsj.ung weight % body weight 
Control E 470 3.3370 0.71 
Sprays A 373 2.4991 0.67 
" B 363 2.3595 0.65 
Pam Injected C 436 2.7468 0.63 
Saline Injected D 457 3.1076 0.68 
60 Days 
Control E 627 4.5144 0.72 
Sprays A 453 2.8086 0.62 
" B 538 3.6584 0.68 
Pam Injected C 601 4.8080 0.80 
Saline Injected D 550 3.1900 0.58 
130 Days 
Control E 740 5.1800 0.70 
Sprays A 652 5.2812 0.81 
" B 730 5.6940 0.78 
Pam Injected C 717 4.9473 0.69 
Saline Injected D 819 5.7330 0.70 
180 Days 
Control E 910 6.0060 0.66 
Sprays A 707 5.5853 0.79 
" B 698 4.9558 0.71 
Pam Injected C 785 5.7305 0.73 
Saline Injected D 846 5.8374 0.69 

Ill 
Figure 1. Composition of Commercial Lecithin 
CH -O-S-R' | 0 
CH_-0-$-0-CH„-CH„-N -(CH )_ 
2 [j- 2 2 3 3 
Phosphatidyl choline (chemical lecithin) 
0 
ii 
Phosphatidyl ethanolamine (cephalin) 
r.H -n-r.-R 
OH OH 
X = one or more phosphatide group 
linked to one or more sugar 
molecules 
Phosphatidyl inositol 
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Figure 2. Oil within bronchiole. This preliminary guinea 
pig was sacrificed immediately following an intratracheal 
injection of 0.05 cc Pam. (Oil red 0, x 100) 
Figure 3. Giant cells containing refractile material, Pam 
injecced 7 day animal. (Hematoxylin/eosin, x 250) 
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Figure 4. Foamy histiocytes within a large area of focal 
MNC infiltrate, Pam injected 21 day animal. (Hematoxylin/ 
eosin, x 250) 
Figure 5. Focal MNC infiltrate, sprays 21 day animal. This 
demonstrates the most common histological finding in Pam 
exposed animals. (Hematoxylin/eosir , x 100) 

70 
Figure 6. Oil lining a large bronchiole, within the surround- 
cellular infiltrate, and within monocytic cells 60 days after 
intratracheal injection of 0.05 cc Pam, (group C). Only a 
small portion of the bronchiole is shown; the remaining portion 
was similar. (Oil red 0, x 250) 
Figure 7. Oil within a bronchiole 172 days after 10 intratra- 
tracheal injections of 0.05 cc Pam, guinea pig G. Elsewhere 
tiny oil droplets were noted withir monocytic cells. (Oil 
red 0, x 250) 
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Figure 8. Small giant cell and foamy histiocytes within a 
large area of MNC infiltrate, guinea pig F. (Hematoxylin/ 
eosin, x 400) 
Figure 9. Peribronchial lymphoid hyperplasia, 30 days sprayed 
(A) animal. (Hematoxylin/eosin, x ^0) 
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